IP Library Granted Patent US 10,351,600
Granted Patent B2
US 10,351,600 · App. 15/663,043 · Granted Jul 16, 2019

Peptide and complex of same, scaffold for tissue repair and surface treatment method for same, and surface treatment solution or set of treatment solutions

Inventors: Tetsuji Yamaoka (Suita, JP); Sachiro Kakinoki (Suita, JP); Shunsuke Baba (Osaka, JP); Yoshiya Hashimoto (Osaka, JP)
Assignees: National Cerebral and Cardiovascular Center; JMS Co., Ltd.
C07K7/08A61L27/12A61L27/54A61L27/58C07K9/00C07K14/50A61L2300/236A61L2300/25A61L2300/414
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,351,600
App. No.
15/663,043
Granted
Jul 16, 2019
Kind
B2
Abstract

A peptide that enables surface treatment of a scaffold for tissue repair that makes it possible to accelerate the repair of living tissue without using a material that negatively affects the repair of living tissue, a complex containing this peptide, a scaffold for tissue repair surface treated using this peptide or this complex, a surface treatment method for a scaffold for tissue repair using this peptide or this complex, and a treatment solution or set of treatment solutions to be used in this surface treatment method. Surface treatment of a scaffold for tissue repair is conducted by combining glycosaminoglycan and a peptide containing adhesive sites and basic sites each comprising predetermined amino acid residues.

Claims (12)

1. A complex of peptide and glycosaminoglycan,

wherein the peptide comprises, in the amino acid sequence thereof, an adhesive site consisting of residues of amino acids including a 2,3-dihydroxyphenyl group or 3,4-dihydroxyphenyl group, and a basic site including three or more consecutive basic amino acid residues;

wherein the adhesive site and the basic site bind via a spacer site, and

wherein the glycosaminoglycan is binding at the basic site.

2. The complex according to claim 1 , wherein a sequence of nine resides from the C terminus of the peptide is an amino acid sequence represented by SEQ ID NO 1.

3. A complex of the complex according to claim 1 and a cell growth factor,

wherein the cell growth factor is binding with the glycosaminoglycan.

4. A scaffold for tissue repair, wherein the complex according to claim 1 is binding to the surface thereof at the adhesive site.

5. A scaffold for tissue repair, wherein a complex of the complex according to claim 1 and a cell growth factor are binding to a surface of the scaffold at the adhesive site.

6. A treatment solution for surface treatment of a scaffold for tissue repair, comprising the complex according to claim 1 .

7. A set of treatment solutions for surface treatment of a scaffold for tissue repair, comprising the treatment solution according to claim 6 and a treatment solution containing cell growth factor.

8. A treatment solution for surface treatment of a scaffold for tissue repair, comprising a complex of the complex according to claim 1 and a cell growth factor.

Priority Claims (1)
JP 2013-094744 · Apr 26, 2013 · national
Continuity (2)
Division 14787228
Related Publication 20170327539A1 · Nov 16, 2017